Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response.
about
Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityEnhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive LiposomesTumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed.Wide-field functional imaging of blood flow and hemoglobin oxygen saturation in the rodent dorsal window chamberCationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients.Intravital microscopy as a tool to study drug delivery in preclinical studies.A robust approach to enhance tumor-selective accumulation of nanoparticles.Cancer drug delivery: considerations in the rational design of nanosized bioconjugates.Systemic use of tumor necrosis factor alpha as an anticancer agentLight Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas.PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity.Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumorsSystemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.Tumor vasculature as target for therapeutic intervention.Nanocapsules of platinum anticancer drugs: development towards therapeutic use.Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity.Liposomes, a promising strategy for clinical application of platinum derivatives.Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors.Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationStrategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Improved Efficacy of Liposomal Doxorubicin Treatment of Superficial Tumors by Thermotherapy.Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids.Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors.Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer.Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy.Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-Alpha.Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice.The efficacy and hyperthermic release of doxorubicin from liposomal doxorubicin hydrochloride in rabbit VX2 tumours.Spatiotemporal endothelial cell - pericyte association in tumors as shown by high resolution 4D intravital imaging.Regional heterogeneity changes in DCE-MRI as response to isolated limb perfusion in experimental soft-tissue sarcomas
P2860
Q26999332-F51D2C31-255E-4207-8786-B6CDEA0AADF8Q27308658-2C2D94AA-D9CE-4C05-9066-8EFCDE5D87A5Q27314854-CF774BC8-D9CC-43E2-9967-D385FA531D2CQ33325343-F771C54A-C280-455F-B63E-90B3D9D9B6E7Q33970699-C826F109-DB33-4DD6-BD86-6F5A406608A5Q34022435-3A6F0BA3-29C4-45A9-BA65-8FD30983CB60Q34030709-E477660D-A86C-44B7-AD4F-78FECFAB28FFQ34054797-62151084-C32B-425B-A199-BABE61C14CC0Q34507643-2DEEF136-1536-4088-8D02-69B9247230CCQ34754720-8B0701AF-31C2-42EE-AA55-B345222E919AQ34764424-7BBE83A1-5B7E-4461-9CC4-495217C1C360Q35640180-0BDB4043-56A8-4783-9484-576D05BBDB9AQ35922404-5A6D2F5A-BDDB-44EB-995E-A79B1E097710Q35974293-BA72D15E-1BDF-4A5B-8B7B-85FFFA0882D1Q36316684-A443CF42-5482-4B74-86A1-C464EEAAD59FQ36383059-AAF67E59-D560-4E8F-9479-4ECDFE2AC6BEQ36454792-6C3B2F44-F005-456B-B07F-B5CBAB8E73AEQ36673686-1E602AF0-09FF-459A-BB77-4DB135DED995Q37476252-146BDD5E-C511-454D-AF6D-6D93F90883E3Q37800110-54DEE05E-F041-4D5C-A975-421F3D0FD3FEQ37855865-A8A52CF2-3505-4FF2-A66E-A411BCF729F4Q37865021-A727E0F8-2F2D-4DE2-8D4F-1BBC19E340E3Q38087423-DDD8FA3D-75B7-4EA4-BE4F-ECD117ED4B62Q38098811-CC5FFE5D-680F-4F99-9CB5-800BD4ECA004Q38169752-C86711F9-CC64-4E75-BFEB-EB258E47D955Q38273670-852C5B42-E287-47B9-98ED-EAA324E680A1Q38634048-59E652D6-FD60-4874-A581-0FF78515AA44Q38776676-58D9AFF6-B929-4ACC-B57A-E056EE8D410CQ38886003-0CDE5128-AB8A-4B49-AC45-6B81D367A0ECQ39153169-2A899599-AA90-4641-8B09-8450116BBC8EQ40360218-5C0A9817-0D1A-4A8B-9FF1-B340163CA19FQ42290164-8708848E-6EF8-4813-A14A-F6A50516DD40Q42708321-40F78202-47B6-4B57-B559-66DA0D0CA9C2Q48359300-389252C5-39B8-4CC7-B2C0-7B2383B77C0CQ49334996-07F60C6F-AE1D-4F01-8CFD-C4C95245D0A5Q50010466-2E67A6B6-11A7-40F4-B72F-D37C8470C1FCQ50273556-C1279C72-1055-4475-B4D3-400BD7531AB4Q55443292-E487DF8A-AA62-4001-9E7F-9C4C6AE2D5AFQ57719785-91899456-B661-4765-B439-6B8BA6C65604
P2860
Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tumor necrosis factor alpha me ...... es to a better tumor response.
@ast
Tumor necrosis factor alpha me ...... es to a better tumor response.
@en
Tumor necrosis factor alpha me ...... es to a better tumor response.
@nl
type
label
Tumor necrosis factor alpha me ...... es to a better tumor response.
@ast
Tumor necrosis factor alpha me ...... es to a better tumor response.
@en
Tumor necrosis factor alpha me ...... es to a better tumor response.
@nl
prefLabel
Tumor necrosis factor alpha me ...... es to a better tumor response.
@ast
Tumor necrosis factor alpha me ...... es to a better tumor response.
@en
Tumor necrosis factor alpha me ...... es to a better tumor response.
@nl
P2093
P1433
P1476
Tumor necrosis factor alpha me ...... es to a better tumor response.
@en
P2093
Alexander M M Eggermont
Ann L B Seynhaeve
Cindy E Vermeulen
Debby Schipper
Gisela aan de Wiel-Ambagtsheer
Sandra T van Tiel
Saske Hoving
Timo L M Ten Hagen
P304
P356
10.1158/0008-5472.CAN-07-1599
P407
P577
2007-10-01T00:00:00Z